Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Regeneron Pharmaceuticals Inc. Stock

Price
Target price
€640.00

€640.00

3.060%
19.0
3.060%
€705.36
 
16:29 / Tradegate WKN: 881535 / Symbol: REGN / Name: Regeneron / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Regeneron Pharmaceuticals Inc. in the next few years
Wizard

Regeneron Pharmaceuticals Inc. Stock

A very strong showing by Regeneron Pharmaceuticals Inc. today, with an increase of €19.00 (3.060%) compared to yesterday's price.
The stock is one of the favorites of our community with 37 Buy predictions and 2 Sell predictions.
With a target price of 705 € there is a slightly positive potential of 10.16% for Regeneron Pharmaceuticals Inc. compared to the current price of 640.0 €.
So far the community has only identified positive things for Regeneron Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.

Pros and Cons of Regeneron Pharmaceuticals Inc. in the next few years

Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Regeneron Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Regeneron Pharmaceuticals Inc. 3.060% 0.129% 9.679% -16.036% -8.190% -12.842% 57.335%
Incyte Corp. 0.050% -6.483% -11.218% 18.221% 23.798% 2.070% 20.373%
Exact Sciences -2.230% -0.288% 50.408% 48.093% 59.231% 104.318% -20.879%
Amgen Inc. 0.300% -8.871% -3.679% 2.920% 7.623% 1.928% 43.431%

Comments

Prediction Buy
Perf. (%) 1.34%
Target price 728.790
Change
Ends at 04.12.26

Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at BMO Capital Markets from $725.00 to $850.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
Show more

BMO Capital Markets 
0
Report Share
04.12.25
Prediction Buy
Perf. (%) -5.09%
Target price 693.223
Change
Ends at 24.11.26

Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $798.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Show more

Truist Financial Co. 
0
Report Share
24.11.25
Prediction Buy
Perf. (%) -4.32%
Target price 221.519
Change
Ends at 24.11.26

Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $255.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Show more

HSBC Holdings plc 
0
Report Share
24.11.25
Show more
Not a member yet? Sign up for free!

News

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?: https://g.foolcdn.com/editorial/images/844505/patient-talking-with-a-physician.jpg
Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?

Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the company navigates challenges to one of its main growth drivers, Eylea. This

TheMotleyFool 
0 01.12.25
1 Reason Why Shares of Regeneron Pharmaceuticals Are Surging This Month: https://g.foolcdn.com/editorial/images/843338/surprised-investor-works-at-computer.jpg
1 Reason Why Shares of Regeneron Pharmaceuticals Are Surging This Month

After climbing 2.3% in October, the S&P 500 has taken a U-turn and driven steadily lower over the past few weeks. From the start of November through Nov. 21, the index has dipped about 3.5%.

But

TheMotleyFool 
0 24.11.25
2 Beaten-Down Stocks That Could Be About to Rally: https://g.foolcdn.com/editorial/images/839899/doctor-and-patient-talking.jpg
2 Beaten-Down Stocks That Could Be About to Rally

What's better than investing in a stock with a promising outlook? Investing in a beaten-down stock with a promising outlook. Scooping up shares of great companies after they have experienced

TheMotleyFool 
0 03.11.25